These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29520737)

  • 1. MPS-IIIA mice acquire autistic behaviours with age.
    Lau AA; Tamang SJ; Hemsley KM
    J Inherit Metab Dis; 2018 Jul; 41(4):669-677. PubMed ID: 29520737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test.
    Langford-Smith A; Langford-Smith KJ; Jones SA; Wynn RF; Wraith JE; Wilkinson FL; Bigger BW
    PLoS One; 2011; 6(10):e25717. PubMed ID: 22028789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.
    Crawley AC; Gliddon BL; Auclair D; Brodie SL; Hirte C; King BM; Fuller M; Hemsley KM; Hopwood JJ
    Brain Res; 2006 Aug; 1104(1):1-17. PubMed ID: 16828069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).
    Hemsley KM; Hopwood JJ
    Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice.
    Lau AA; Crawley AC; Hopwood JJ; Hemsley KM
    Behav Brain Res; 2008 Aug; 191(1):130-6. PubMed ID: 18453006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA.
    Rumsey RK; Rudser K; Delaney K; Potegal M; Whitley CB; Shapiro E
    J Pediatr; 2014 May; 164(5):1147-1151.e1. PubMed ID: 24582005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.
    King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM
    J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α-synuclein.
    Soe K; Beard H; Neumann D; Trim PJ; Duplock S; Snel MF; Hopwood JJ; Hemsley KM
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):715-731. PubMed ID: 30907009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells.
    Keating DJ; Winter MA; Hemsley KM; Mackenzie KD; Teo EH; Hopwood JJ; Brooks DA; Parkinson-Lawrence EJ
    Neuroscience; 2012 Dec; 227():110-8. PubMed ID: 23022219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Engineered
    Douek AM; Amiri Khabooshan M; Henry J; Stamatis SA; Kreuder F; Ramm G; Änkö ML; Wlodkowic D; Kaslin J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.
    Lau AA; King BM; Thorsen CL; Hassiotis S; Beard H; Trim PJ; Whyte LS; Tamang SJ; Duplock SK; Snel MF; Hopwood JJ; Hemsley KM
    J Inherit Metab Dis; 2017 Sep; 40(5):715-724. PubMed ID: 28451919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder.
    King B; Setford ML; Hassiotis S; Trim PJ; Duplock S; Tucker JN; Hattersley K; Snel MF; Hopwood JJ; Hemsley KM
    Exp Neurol; 2016 Apr; 278():11-21. PubMed ID: 26626972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA.
    McIntyre C; Derrick Roberts AL; Ranieri E; Clements PR; Byers S; Anson DS
    Mol Genet Metab; 2008 Apr; 93(4):411-8. PubMed ID: 18248829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders.
    De Risi M; Tufano M; Alvino FG; Ferraro MG; Torromino G; Gigante Y; Monfregola J; Marrocco E; Pulcrano S; Tunisi L; Lubrano C; Papy-Garcia D; Tuchman Y; Salleo A; Santoro F; Bellenchi GC; Cristino L; Ballabio A; Fraldi A; De Leonibus E
    Nat Commun; 2021 Jun; 12(1):3495. PubMed ID: 34108486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of prenatal vitamin D deficiency on autism-relevant behaviours in multiple inbred strains of mice.
    Langguth M; Fassin M; Alexander S; Turner KM; Burne THJ
    Behav Brain Res; 2018 Aug; 348():42-52. PubMed ID: 29655594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA.
    Roberts AL; Rees MH; Klebe S; Fletcher JM; Byers S
    Mol Genet Metab; 2007; 92(1-2):115-21. PubMed ID: 17681480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
    Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA.
    Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV
    Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High maternal choline consumption during pregnancy and nursing alleviates deficits in social interaction and improves anxiety-like behaviors in the BTBR T+Itpr3tf/J mouse model of autism.
    Langley EA; Krykbaeva M; Blusztajn JK; Mellott TJ
    Behav Brain Res; 2015 Feb; 278():210-20. PubMed ID: 25300468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease.
    Saville JT; Derrick-Roberts ALK; McIntyre C; Fuller M
    Hum Gene Ther; 2021 Apr; 32(7-8):420-430. PubMed ID: 33339477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.